Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Bryan Tolliver and James Prisciandaro.
Connection Strength

5.338
  1. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders. Addict Biol. 2022 01; 27(1):e13085.
    View in: PubMed
    Score: 0.839
  2. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res. 2021 Jan; 295:112904.
    View in: PubMed
    Score: 0.761
  3. An evaluation of the impact of co-occurring anxiety and substance use disorder on bipolar disorder illness outcomes in STEP-BD. J Affect Disord. 2019 03 01; 246:794-799.
    View in: PubMed
    Score: 0.699
  4. An item response theory evaluation of the young mania rating scale and the montgomery-asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD). J Affect Disord. 2016 Nov 15; 205:73-80.
    View in: PubMed
    Score: 0.590
  5. Evidence for the continuous latent structure of mania and depression in out-patients with bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Psychol Med. 2015; 45(12):2595-603.
    View in: PubMed
    Score: 0.541
  6. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcohol Clin Exp Res. 2012 Mar; 36(3):490-6.
    View in: PubMed
    Score: 0.422
  7. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res. 2011 Aug 15; 188(3):361-5.
    View in: PubMed
    Score: 0.414
  8. Predictors of clinical trial dropout in individuals with co-occurring bipolar disorder and alcohol dependence. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):493-6.
    View in: PubMed
    Score: 0.411
  9. A Multimethod Examination of Sensitivity to Reward and Sensitivity to Punishment in Bipolar Disorder and Alcohol Dependence: Results from a 2 ? 2 Factorial Design. Psychopathology. 2021; 54(2):70-77.
    View in: PubMed
    Score: 0.203
  10. Delay discounting and reward sensitivity in a 2 ? 2 study of bipolar disorder and alcohol dependence. Addiction. 2019 08; 114(8):1369-1378.
    View in: PubMed
    Score: 0.179
  11. Identification and initial validation of empirically derived bipolar symptom states from a large longitudinal dataset: an application of hidden Markov modeling to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study. Psychol Med. 2019 05; 49(7):1102-1108.
    View in: PubMed
    Score: 0.171
  12. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord. 2012 Feb; 14(1):54-63.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.